GSE125112
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined  with all-trans retinoic acid in acute myeloid leukemia across   subtypes
Combined treatment with all-trans retinoic acid and GSK2879552 results in synergistic effects on gene expression, cell proliferation, markers   of differentiation, and, most importantly, cytotoxicity. Overall design: Gene expression analysis of DMSO, single and combination treatment (ATRA and GSK2879552) on 6 AML cell lines at two time-points with two replicates (paired end RNA-seq on 96 samples in total)